BCMA-Targeting Bispecific Antibodies Reframe RRMM Outlook
BCMA-Targeting Bispecific Antibodies Reframe RRMM Outlook is organized by Projects In Knowledge Inc. (PIK).
Release Date: Feb 24, 2023
Termination Date: Feb 23, 2024
Activity Goal:
The goal of this program is to provide data from medical meetings, expert analysis insights on current and emerging management strategies, and interactive case studies based on the most up-to-date evidence-based medicine and clinical trial results in BCMA-targeted RRMM.
Learning Objective(s):
• Appraise available efficacy and safety data from key clinical trials focused on BCMA-targeted treatments for late RRMM.
• Review treatment-related toxicities associated with BCMA-targeted therapies and strategies for optimal management of toxicities.
Additional details will be posted as soon as information is available.